Shopping Cart
- Remove All
- Your shopping cart is currently empty
Rufinamide (E 2080), a triazole derivative, is used as voltage-gated sodium channel blocker for the treatment of seizure disorders.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $56 | In Stock | |
50 mg | $93 | In Stock | |
100 mg | $179 | In Stock | |
200 mg | $268 | In Stock | |
1 mL x 10 mM (in DMSO) | $50 | In Stock |
Description | Rufinamide (E 2080), a triazole derivative, is used as voltage-gated sodium channel blocker for the treatment of seizure disorders. |
In vitro | Rufinamide effectively suppresses maximal electroshock (MES)-induced tonic convulsions in mice (ED50 = 23.9 mg/kg) and rats (ED50 = 6.1 mg/kg). Additionally, Rufinamide inhibits pentylenetetrazol-(ED 50=54.0), bicuculline-(ED 50=50.5), and picrotoxin (ED 50=76.3 mg/kg) provoked clonic seizures in mice. Furthermore, it prevents pentylenetetrazole-induced epileptic seizures in mice at an effective dose of 45.8 mg/kg (ED50). |
In vivo | Rufinamide inhibits sodium-dependent action potentials in neurons, potentially exhibiting membrane stabilizing effects. |
Alias | RUF 331, E 2080, CGP 33101 |
Molecular Weight | 238.19 |
Formula | C10H8F2N4O |
Cas No. | 106308-44-5 |
Smiles | NC(=O)C1=CN(CC2=C(F)C=CC=C2F)N=N1 |
Relative Density. | 1.52 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 16.67 mg/mL (69.97 mM), Sonication is recommended. Ethanol: < 1 mg/mL (insoluble or slightly soluble) | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.